from Reuters: Health News https://ift.tt/386VrMt
via IFTTT
Wednesday, December 4, 2019
AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment
AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a from of ovarian cancer.
from Reuters: Health News https://ift.tt/386VrMt
via IFTTT
from Reuters: Health News https://ift.tt/386VrMt
via IFTTT
0 comments:
Post a Comment